146 related articles for article (PubMed ID: 35310188)
21. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
22. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis.
Zhang H; Bao M; Liao D; Zhang Z; Tian Z; Yang E; Luo P; Jiang X
Med Oncol; 2023 Apr; 40(6):161. PubMed ID: 37099121
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis.
Xu H; Xu Q; Yin L
Cancer Cell Int; 2021 Jul; 21(1):344. PubMed ID: 34217290
[TBL] [Abstract][Full Text] [Related]
24. The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma.
Yu J; Lai M; Zhou Z; Zhou J; Hu Q; Li J; Li H; Chen L; Wen L; Zhou M; Cai L
J Neuroimmunol; 2023 Mar; 376():578034. PubMed ID: 36791582
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy.
Zhao R; Pan Z; Li B; Zhao S; Zhang S; Qi Y; Qiu J; Gao Z; Fan Y; Guo Q; Qiu W; Wang S; Wang Q; Zhang P; Guo X; Deng L; Xue H; Li G
Front Immunol; 2022; 13():820673. PubMed ID: 35309323
[TBL] [Abstract][Full Text] [Related]
26. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy.
Li C; Pan J; Jiang Y; Yu Y; Jin Z; Chen X
Front Genet; 2021; 12():793628. PubMed ID: 35069691
[No Abstract] [Full Text] [Related]
28. Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.
Li H; He J; Li M; Li K; Pu X; Guo Y
Front Immunol; 2022; 13():1027631. PubMed ID: 36532035
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the immune cell infiltration landscape in bladder cancer to aid immunotherapy.
Shi S; Ma T; Xi Y
Arch Biochem Biophys; 2021 Sep; 708():108950. PubMed ID: 34118215
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the Immune Cell Infiltration Landscape of Thyroid Cancer for Improved Immunotherapy.
Gong J; Jin B; Shang L; Liu N
Front Mol Biosci; 2021; 8():714053. PubMed ID: 34790698
[TBL] [Abstract][Full Text] [Related]
31. Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma.
Liu R; Liang W; Hua Q; Wu L; Wang X; Li Q; Zhong F; Li B; Qiu Z
Front Immunol; 2022; 13():819515. PubMed ID: 35251000
[TBL] [Abstract][Full Text] [Related]
32. An immune cell infiltration landscape classification to predict prognosis and immunotherapy effect in oral squamous cell carcinoma.
Yang Z; He F
Comput Methods Biomech Biomed Engin; 2024; 27(2):191-203. PubMed ID: 36794748
[TBL] [Abstract][Full Text] [Related]
33. Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma.
Qin H; Wang T; Zhang H
Front Genet; 2022; 13():906113. PubMed ID: 35846133
[No Abstract] [Full Text] [Related]
34. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
35. Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy.
Li X; Liang W; Zhao H; Jin Z; Shi G; Xie W; Wang H; Wu X
Front Cell Dev Biol; 2021; 9():749157. PubMed ID: 34805159
[TBL] [Abstract][Full Text] [Related]
36. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
37. The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis.
Zhang Y; Wang Y; Wang J; Zhang K
Front Genet; 2022; 13():852708. PubMed ID: 35801082
[No Abstract] [Full Text] [Related]
38. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J
Front Immunol; 2020; 11():585034. PubMed ID: 33193404
[TBL] [Abstract][Full Text] [Related]
39. Higher cytolytic score correlates with an immunosuppressive tumor microenvironment and reduced survival in glioblastoma.
Haddad AF; Chen JS; Oh T; Pereira MP; Joshi RS; Aghi MK
Sci Rep; 2020 Oct; 10(1):17580. PubMed ID: 33067480
[TBL] [Abstract][Full Text] [Related]
40. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
